Haphazard cholesterol checks put Australians at risk of heart disease

March 8, 2018, University of Sydney

A research team from Western Sydney University, Capital Markets CRC, University of Sydney and University of Adelaide did an analysis of publicly available, linked patient records within the electronic databases of the Medicare Benefit Schedule (MBS) and Pharmaceutical Benefit Scheme (PBS).

The results reveal:

  • 49 per cent of patients on medications to lower their did not have the recommended annual HDL-C in a given year.
  • 19 per cent of the same population received more HDL-C tests than were necessary.
  • the yearly expenditure associated with test overutilisation was approximately A$4.3 million, while the cost averted because of test underutilisation was approximately A$11.3 million per year.

Using the PBS data, the researchers collated the de-identified records of patients who received stable prescriptions of cholesterol lowering medications over a 7-year period from 2008 to 2014 - who could therefore be determined as being at high risk of developing heart disease.

As are linked to the MBS, it was then possible to determine if these same patients received the recommended, annual High-Density Lipoprotein-Cholesterol (HDL-C) test from their GP.

Dr Evan Atlantis, from the School of Nursing and Midwifery at Western Sydney University, says the results suggest that one fifth of patients are receiving too many, unnecessary tests - while half are not having their sufficiently monitored.

"Cholesterol tests are being administered in a haphazard manner - with some patients being tested too frequently and others not enough," says Dr Atlantis.

The BMJ Open paper explores several possible explanations for this finding. One points to a lack in continuity of care and to the fact that often people see multiple practitioners at once.

"If there is no designated 'medical home' for the patient, it is not clear who bears the responsibility for managing cardiovascular risk. In this scenario, it is not surprising that many individuals may miss their annual cholesterol tests," says Dr Atlantis.

"Another contributing factor may be the lack of continuity in medical records. It is entirely possible that practitioners are not aware that some of their are on cholesterol medications and therefore do not take the recommended action in ordering tests.

"Another possibility is that medical practitioners are making a clinical choice not to follow the current guidelines on blood cholesterol monitoring."

Dr Atlantis - together with co-researcher Dr Katy Bell from the University of Sydney - suggests that medical practitioners' widespread non-adherence may be evidence that the guidelines warrant review.

"If there is high level evidence that the recommended frequency of tests leads to improved health outcomes, then the potential underutilisation of these tests in Australia warrants further attention," says Dr Bell.

The study also identified the Federal Health Budget implications of the underutilisation of cholesterol tests.

During the study period, the yearly expenditure associated with test overutilisation was approximately A$4.3 million, while the cost averted because of test underutilisation was approximately A$11.3 million per year.

"While cost-saving, the long term health consequences of under-utilising HDL-C test are unknown and any increase in in Australia would result in a financial burden that cannot be ignored," says Dr Atlantis.

Farshid Hajati - who developed the methodology to conduct the study and analysed the data - pointed out that there is great potential for data of this type to benefit the public.

"The next step is to quantify the consequences of not receiving the recommended level of cholesterol testing, to strengthen the current recommendations on testing frequency."

Explore further: Follow-up cholesterol testing reduces risk of reocurrence for heart attack and stroke patients

Related Stories

Follow-up cholesterol testing reduces risk of reocurrence for heart attack and stroke patients

November 13, 2017
If you have a heart attack or stroke, it's important to get your "bad" cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering ...

Photographic cholesterol test

August 17, 2012
Researchers in India have developed a total cholesterol test that uses a digital camera to take a snapshot of the back of the patient's hand rather than a blood sample. The image obtained is cropped and compared with images ...

Simple, common BMI data stored in e-records can identify patients with heart disease risk

March 13, 2012
Electronic medical records provide new opportunities to monitor and improve patients’ health. New research released online in the American Journal of Preventive Medicine shows that body mass index (BMI) data, commonly ...

Test for HDL cholesterol function could transform the way healthcare providers predict risk for heart disease

June 6, 2017
A groundbreaking study published today in AACC's Journal of Applied Laboratory Medicine shows that a new test could improve diagnosis and treatment of heart disease by measuring how effectively a patient's high-density lipoprotein ...

Less than half of patients prescribed new cholesterol drug receive insurance approval

October 30, 2017
Less than half of patients received their insurer's approval for prescriptions of PCSK9 inhibitors, according to new research in the American Heart Association's journal Circulation.

What you need to know about cholesterol

March 28, 2017
(HealthDay)—Cholesterol plays a vital role in your health, so it's important to understand the different types of cholesterol and how to influence their levels, a heart specialist says.

Recommended for you

Exercise may be as effective as prescribed drugs to lower high blood pressure

December 18, 2018
Exercise may be as effective as prescribed drugs to lower high (140 mm Hg) blood pressure, suggests a pooled analysis of the available data, in what is thought to be the first study of its kind, and published online in the ...

Can stem cells help a diseased heart heal itself? Researchers achieve important milestone

December 14, 2018
A team of Rutgers scientists, including Leonard Lee and Shaohua Li, have taken an important step toward the goal of making diseased hearts heal themselves—a new model that would reduce the need for bypass surgery, heart ...

Your weight history may predict your heart failure risk

December 12, 2018
In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide ...

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

Age is the biggest risk for heart disease, but lifestyle and meds have impact

December 12, 2018
Of all the risk factors for heart disease, age is the strongest predictor of potential trouble.

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.